Topical aspects of the use of phytopreparations in acute rhinosinusitis
https://doi.org/10.21518/ms2025-122
Abstract
Acute rhinosinusitis is a common pathological condition characterized by inflammatory changes in the nasal mucosa and paranasal sinuses. This inflammation leads to the development of a variety of clinical symptoms that can significantly impair the quality of life of patients. In recent years, there has been a growing interest in the pathogenesis of this condition, which Underlines the need for an integrated approach to its diagnosis and therapy: the use of herbal medicines is becoming an increasingly relevant area in the treatment of rhinosinusitis. Ivy leaf extract appears as a promising phytotherapeutic agent with the potential for effective treatment of acute infectious and inflammatory diseases of the upper respiratory tract. This herbal extract contains a wide range of biologically active compounds, including saponins, flavonoids and glycosides, which largely determine its therapeutic properties and mechanism of action. According to extensive scientific literature data, ivy leaf extract preparations demonstrate the ability to effectively reduce the clinical manifestations of acute rhinosinusitis. The article presents a clinical observation of a patient with acute rhinosinusitis. Complex therapy with the inclusion of a herbal preparation was prescribed. There were observed good tolerability of the treatment and the absence of adverse drug effects.
About the Authors
G. N. Nikiforova
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Galina N. Nikiforova - Dr. Sci. (Med.), Professor, Professor of Ear, Nose and Throat Department, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University).
6, Bldg. 1, Bolshaya Pirogovskaya St., Moscow, 119991
A. A. Khlytina
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Arina A. Khlytina - Postgraduate Student of Ear, Nose and Throat Department, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University).
6, Bldg. 1, Bolshaya Pirogovskaya St., Moscow, 119991
A. V. Struve
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Andrey V. Struve - Teaching Assistant of Ear, Nose and Throat Department, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University).
6, Bldg. 1, Bolshaya Pirogovskaya St., Moscow, 119991
V. V. Elizarova
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Viktoriia V. Elizarova - Teaching Assistant of Ear, Nose and Throat Department, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University).
6, Bldg. 1, Bolshaya Pirogovskaya St., Moscow, 119991
References
1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;(29 Suppl.):1–464. https://doi.org/10.4193/Rhin20.600.
2. Карнеева ОВ, Гуров АВ, Карпова ЕП, Тулупов ДА, Рязанцев СВ, Гаращенко ТИ и др. Острый синусит: клинические рекомендации. М.; 2021. 53 с. Режим доступа: https://diseases.medelement.com/disease/острый-синусит-кп-рф-2021/16940. .
3. Gliklich RE, Metson R. Economic implications of chronic sinusitis. Otolaryngol Head Neck Surg. 1998;118(1):344–349. https://doi.org/10.1016/S0194-59989870313-4.
4. Лопатин АС (ред.). Острый риносинусит: клинические рекомендации. М.; 2017. 36 с. Режим доступа: https://rumedo.ru/uploads/sites/2/2019/03/Lopatin-A.S.-Ostryy-rinosinusit-klinicheskie-rekomendacii-2017.pdf.
5. Kryukov AI, Turovskiy AB. Antibiotic therapy for acute otitis media and sinusitis in adults in outpatient settings. RMJ. 2004;(21):1188. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Antibakterialynaya_terapiya_ostrogo_srednego_otita_i_sinusita_u_vzroslyh_v_ambulatornoy_praktike.
6. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M et al. Clinical practice guideline (update): Adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl.):S1-S39. https://doi.org/10.1177/0194599815572097.
7. Esposito S, Marchisio P, Tenconi R, Tagliaferri L, Albertario G, Patria MF, Principi N. Diagnosis of acute rhinosinusitis. Pediatr Allergy Immunol. 2012;23(22 Suppl.):17–19. https://doi.org/10.1111/j.1399-3038.2012.01319.x.
8. Derbeneva ML, Guseva AL. Acute rhinosinusitis: diagnosis and treatment. Consilium Medicum. 2018;20(3):58–60. (In Russ.) https://doi.org/10.26442/2075-1753_20.3.58-60.
9. Smith SS, Ference EH, Evans CT, Tan BK, Kern RC, Chandra RK. The prevalence of bacterial infection in acute rhinosinusitis: A systematic review and meta-analysis. Laryngoscope. 2015;125(1):57–69. https://doi.org/10.1002/lary.24709.
10. Loftus PA, Lin J, Tabaee A. Anatomic variants of the paranasal sinuses in patients with recurrent acute rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(3):328–333. https://doi.org/10.1002/alr.21658.
11. Bittner CB, Plach M, Steindl H, Abramov-Sommariva D, Abels C, Kostev K. Prevalence of Antibiotic Prescription in Patients with Acute Rhinosinusitis Treated by General Practitioners and Otolaryngologists in Germany-A Retrospective Cohort Study. Antibiotics. 2022;11(11):1576. https://doi.org/10.3390/antibiotics11111576.
12. Svistushkin VM, Nikiforova GN, Shevchik EA, Dedova MG. Innovative classes of antibiotics to treat inflammatory diseases of the paranasal sinuses. Lechaschi Vrach. 2014;(2):25. (In Russ.) Available at: https://www.lvrach.ru/2014/02/15435901.
13. Maestre JR, Mateo M, Méndez ML, Aguilar L, Gimenez MJ, Alou L et al. In vitro interference of beta-lactams with biofilm development by prevalent community respiratory tract isolates. Int J Antimicrob Agents. 2010;35(3):274–277. https://doi.org/10.1016/j.ijantimicag.2009.10.020.
14. Svistushkin VM, Selezneva LV, Svistushkin MV, Lebedeva GV, Zinchenko IA. Modern possibilities for treating acute rhinosinusitis using herbal medications. Consilium Medicum. 2024;26(9):562–567. (In Russ.) https://doi.org/10.26442/20751753.2024.9.202975.
15. Eremin SA, Ryazantsev SV, Konoplev OI. Rational choice of antibacterial drug for the treatment of ent organs in outpatient practice. Meditsinskiy Sovet. 2018;(20):8–12. (In Russ.) https://doi.org/10.21518/2079-701X-2018-20-8-12.
16. DeBoer DL, Kwon E. Acute sinusitis. StatPearls. Treasure Island. Florida, USA: StatPearls Publishing LLC; 2022.
17. Рязанцев СВ (ред.). Принципы этиопатогенетической терапии острых синуситов: методические рекомендации. СПб.: Полифорум Групп; 2014. 40 с. Режим доступа: https://staging.rumedo.ru/uploads/sites/2/2019/03/Abdulkerimov-KH.T.-i-dr.-Principy-yetiopatogeneticheskoy-terapii-ostrykh-sinusitov-metodicheskie-rekomendacii.pdf.
18. Starostina SV, Sivokhin DA. Topical therapy in the treatment of patients with acute rhinosinusitis in adults. Consilium Medicum. 2021;23(3):210–215. (In Russ.) https://doi.org/10.26442/20751753.2021.3.200829.
19. Wang LM, Qiao XL, Ai L, Zhai JJ, Wang XX. Isolation of antimicrobial resistant bacteria in upper respiratory tract infections of patients. 3 Biotech. 2016;6(2):166. https://doi.org/10.1007/s13205-016-0473-z.
20. Ovchinnikov AYu, Miroshnichenko NA, Shagramanyan GB, Ryabini VA. Topical treatment of acute rhinosinusitis in outpatient departments. RMJ. 2016;(21):1407–1410. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Roly_mestnoy_terapii_v_lechenii_bolynyh_s_ostrym_rinosinusitom_v_ambulatornyh_usloviyah.
21. Alou L, Giménez MJ, Sevillano D, Aguilar L, González N, Echeverría O et al. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view? J Antimicrob Chemother. 2007;59(4):652–657. https://doi.org/10.1093/jac/dkm015.
22. King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015:CD006821. https://doi.org/10.1002/14651858.CD006821.
23. Tulupov DA, Fedotov FA, Karpova EP, Grabovskaya VA. Current aspects of use of nasal vasoconstrictors and adjunctive agents in pediatric practice. Meditsinskiy Sovet. 2018;(2):114–117. (In Russ.) https://doi.org/10.21518/2079-701X-2018-2-114-117.
24. De Sutter AI, van Driel ML, Kumar AA, Lesslar O, Skrt A. Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst Rev. 2022;1(1):CD004976. https://doi.org/10.1002/14651858.CD004976.pub4.
25. Passali D, Spinosi MC, Crisanti A, Bellussi LM. Mometasone furoate nasal spray: a systematic review. Multidiscip Respir Med. 2016;11:18. https://doi.org/10.1186/s40248-016-0054-3.
26. Hayward G, Heneghan C, Perera R, Thompson M. Intranasal corticosteroids in management of acute sinusitis: a systematic review and meta-analysis. Ann Fam Med. 2012;10(3):241–249. https://doi.org/10.1370/afm.1338.
27. Kryukov AI, Sedinkin AA. Diagnostic and therapeutic technology for acute bacterial sinusitis. Rossiiskaya Otorinolaringologiya. 2005;(4):5–17. (In Russ.) Available at: http://elib.fesmu.ru/Article.aspx?id=137059.
28. Рязанцев СВ. Острый синусит. Подходы к терапии. М.; 2003. 16 с.
29. Goh YH, Goode RL. Current status of topical nasal antimicrobial agents. Laryngoscope. 2000;110(6):875–880. https://doi.org/10.1097/00005537-200006000-00001.
30. Ryazansev SV, Krivopalov AA, Eremin SA, Zakharova GP, Shabalin VV, Shamkina PA, Chufistova AV. Topical antibacterial therapy for acute rhinosinusitis. RMJ. 2020;(4):2–7. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Topicheskaya_antibakterialynaya_terapiya_ostrogo_rinosinusita.
31. Страчунский ЛС, Белоусов ЮБ, Козлов СН (ред.). Практическое руководство по антибактериальной химиотерапии. М.; 2007. 462 с. Режим доступа: https://img-cdn.tinkoffjournal.ru/-/effektivnost-oksolinovoi-mazi-ne-izuchalas-v-rki-prakticheskoe-rukovodstvo-po-antiinfektsionnoi-khimioterapii.pdf.
32. Garashchenko TI. Mucoactive medications in the treatment of diseases of the nose and paranasal sinuses.. RMJ. 2001;9(19):806–808. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Mukoaktivnye_preparaty_v_lechenii_zabolevaniy_nosa_i_okolonosovyh_pazuh.
33. Карнеева ОВ, Юнусов АС, Гуров АВ, Абдулкеримов ХТ, Рязанцев СВ, Карпова ЕП и др. Острый синусит: клинические рекомендации. М.; 2024. 49 с. Режим доступа: https://diseases.medelement.com/disease/острый-синусит-кр-рф-2024/18274.
34. Кукес ВГ (ред.). Междисциплинарные методические рекомендации по современным аспектам фармакотерапии воспалительных заболеваний. М.: Ирбис; 2021. 92 с.
35. Fokkens WJ, Lund VJ, Hopkins Cl, Hellings PW, Kern R, Reitsma S et al. EPOS 2020: European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(29):53–95. https://doi.org/10.4193/Rhin20.600.
36. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12. https://doi.org/10.4193/Rhino12.000.
37. Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739. https://doi.org/10.1002/alr.22741.
38. Brezhneva TA, Samsonova ND, Solodukhina AA, Popova MV, Slivkin AI. Prospects of ivy’s use in medicine. Proceedings of Voronezh State University. Series: Chemistry. Biology. Pharmacy. 2019;(1):127–141. (In Russ.) Available at: https://elibrary.ru/sobfjg.
39. Prozherina Yu. The role of modern herbal remedies in the management of cough. Remedium. 2018;(10):17–19. (In Russ.) Available at: https://elpub.ru/elpub-article/remedium-journal/276.
40. Garashchenko TI, Serebryakova IU, Davudov KS, Korobkin AS. Optimizing the management of smoking patients with acute rhinosinusitis. Meditsinskiy Sovet. 2020;(16):128–132. (In Russ.) https://doi.org/10.21518/2079-701X-2020-16-128-132.
Review
For citations:
Nikiforova GN, Khlytina AA, Struve AV, Elizarova VV. Topical aspects of the use of phytopreparations in acute rhinosinusitis. Meditsinskiy sovet = Medical Council. 2025;(7):66-71. (In Russ.) https://doi.org/10.21518/ms2025-122
Views:
114
Email this article 